With its broad-spectrum activity, Cefilavancin effectively combats drug-resistant pathogens, including methicillin-resistant Staphylococcus aureus (MRSA) and many other Gram-positive organisms. Cefilavancin works by inhibiting cell wall synthesis, leading to bacterial cell death.
CAT# | R2025 |
CAS | 1393900-12-3 |
M.F/Formula | C87H95Cl3N16O28S2 |
M.W/Mr. | 1983.26 |
* Please kindly note that our products and services can only be used to support research purposes (Not for clinical use).
Creative Peptides has accumulated a huge library of peptide knowledge including frontier peptide articles, application of peptides, useful tools, and more!
Carnosine (β-alanyl-l-histidine), containing an imidazole moiety, is an intramuscular dipeptide consisting of β ...
Peptide YY is referred to as PYY. Its structure is highly homologous with pancreatic polypeptide (PP) and neurop ...
Delcasertib, also known as KAI-9803, is a 23-amino acid peptide and δ-protein kinase C (δ-PKC) inhibitor. KAI-9 ...
KAI-1455, a ε-protein kinase C activator in Phase I testing for the treatment of ischemia-induced reperfusion i ...
Perindopril erbumine is an angiotensioncon vertingenzyme (ACE) inhibitor without sulfhydryl group. It is a chi ...